https://orcid.org/0000-0001-5599-9593
References
- Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood). 2004;229(5):393–406.
- Lindequist U, Niedermeyer THJ, Julich WD. The pharmacological potential of mushrooms. Evid Based Complement Alternat Med. 2005;2(3):285–299.
- Aldwinckle J, Kristiansen B. A quality-of-life study in healthy adults supplemented with lentinex® Beta-Glucan of shiitake Culinary-Medicinal mushroom, Lentinus edodes (agaricomycetes). Int J Med Mushrooms. 2020;22(5):407–415.
- Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med. 2006;49(2):159–170.
- Ina K, Kataoka T, Ando T. The use of lentinan for treating gastric cancer. Anticancer Agents Med Chem. 2013;13(5):681–688.
- Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis. 1992;27(2):65–70.
- Ricar J, Pizinger K, Cetkovska P. Shiitake dermatitis: a distinctive clinical entity. Int J Dermatol. 2013;52(12):1620–1621.
- Boels D, Landreau A, Bruneau C, et al. Shiitake dermatitis recorded by french poison control centers - new case series with clinical observations. Clin Toxicol (Phila). 2014;52(6):625–628.
- Adler MJ, Larsen WG. Clinical variability of shiitake dermatitis. J Am Acad Dermatol. 2012;67(4):e140–E141.
- Nguyen AH, Gonzaga MI, Lim VM, et al. Clinical features of shiitake dermatitis: a systematic review. Int J Dermatol. 2017;56(6):610–616.
- StataCorp. 2019. Stata statistical software: Release 16. [Cited 2021 Nov 19]. College Station, TX: StataCorp LLC Available from: https://www.stata.com/statamp/
- Corazza M, Zauli S, Ricci M, et al. Shiitake dermatitis: toxic or allergic reaction? J Eur Acad Dermatol Venereol. 2015;29(7):1449–1451.
- Reis FS, Barros L, Martins A, et al. Chemical composition and nutritional value of the most widely appreciated cultivated mushrooms: an inter-species comparative study. Food Chem Toxicol. 2012;50(2):191–197.
- Zhang Y, Zheng Z, Yang X, et al. A sensitive and rapid radiolabelling method for the in vivo pharmacokinetic study of lentinan. Food Funct. 2018;9(6):3114–3125.
- Zheng Z, Pan X, Wang H, et al. Mechanism of lentinan intestinal absorption: clathrin-mediated endocytosis and Macropinocytosis. J Agric Food Chem. 2021;69(26):7344–7352.
- Zheng Z, Zhang Y, Liu Y, et al. Metabolic degradation of lentinan in liver mediated by CYP450 enzymes and epoxide hydrolase. Carbohydr Polym. 2021;253:117255.
- Adriano AR, Quiroz CD, Acosta ML, et al. Shiitake dermatitis: the first case reported in Brazil. An Bras Dermatol. 2013;88(3):417–419.
- Mak RKH, Wakelin SH. Shiitake dermatitis: the first case reported from a European country. Br J Dermatol. 2006;154(4):800–801.
- Wang H, Cai Y, Zheng Y, et al. Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a Meta-analysis. Cancer Med. 2017;6(10):2222–2233.
- Ade R, Sukut C, Wiser HJ, et al. Shiitake dermatitis demonstrating Köebner phenomenon. Int J Dermatol. 2015;54(5):e179–E181.
- Murata Y, Shimamura T, Tagami T, et al. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol. 2002;2(5):673–689.
- Chen HL, Li DF, Chang BY, et al. Effects of lentinan on broiler splenocyte proliferation, interleukin-2 production, and signal transduction. Poultr Sci. 2003;82(5):760–766.
- Hanaue H, Tokuda Y, Machimura T, et al. Effects of oral lentinan on t-cell subsets in peripheral venous-blood. Clin Ther. 1989;11(5):614–622.
- Mowad C, Nguyen T, Elenitsas R, et al. Bleomycin-induced flagellate dermatitis: a clinical and histopathological review. Br J Dermatol. 1994;131(5):700–702.
- Camouse MM, Swick AR, Ryan CA, et al. Determination of in vivo dose response and allergen-specific T cells in subjects contact-sensitized to squaric acid dibutyl ester. Dermatitis. 2008;19:95–99.